Satralizumab-mwge

From WikiMD's Food, Medicine & Wellness Encyclopedia

(Redirected from Enspryng)

What Is Satralizumab-mwge?

Satralizumab-mwge (ENSPRYNG) is an interleukin-6 (IL-6) receptor antagonist.


What are the uses of this medicine?

This medicine is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

How does this medicine work?

The precise mechanism by which satralizumab-mwge exerts therapeutic effects in NMOSD is unknown but is presumed to involve inhibition of IL-6-mediated signaling through binding to soluble and membrane-bound IL-6 receptors.

Who Should Not Use this medicine ?

This medicine cannot be used in patients with:

Is this medicine FDA approved?

  • It was approved for use in the United States in 2020.

How should this medicine be used?

  • Prior to initiating ENSPRYNG, perform Hepatitis B virus (HBV) screening.
  • ENSPRYNG is contraindicated in patients with active HBV confirmed by positive results for surface antigen [HBsAg] and anti-HBV tests.
  • Prior to every use, determine if there is an active infection.
  • The recommended loading dosage of ENSPRYNG for the first three administrations is 120 mg by subcutaneous injection at Weeks 0, 2, and 4, followed by a maintenance dosage of 120 mg every 4 weeks.

What are the dosage forms and brand names of this medicine?

This medicine is available in fallowing doasage form:

  • As Injection: 120 mg/mL in a single-dose prefilled syringe

This medicine is available in fallowing brand namesː

  • ENSPRYNG

What side effects can this medication cause?

Common possible side effects of this medicine include:

ENSPRYNG may cause serious side effects including:

Infections

  • ENSPRYNG can increase your risk of serious infections some of which can be life-threatening.

Increased liver enzymes

  • Your healthcare provider should order blood tests to check your liver enzymes before and while you are taking ENSPRYNG.
  • Your healthcare provider will tell you if you need to wait to start ENSPRYNG if your liver enzymes are increased.

Low neutrophil count

  • ENSPRYNG can cause a decrease in your neutrophil counts in your blood.

What special precautions should I follow?

  • Delay ENSPRYNG administration in patients with an active infection until the infection is resolved.
  • Vaccination with live or live-attenuated vaccines is not recommended during treatment.
  • Mild and moderate elevations of liver enzymes have been observed in patients treated with ENSPRYNG at a higher incidence than in patients receiving placebo. Monitor ALT and AST levels during treatment; interruption of ENSPRYNG may be required.
  • Decreases in neutrophil counts were observed in patients treated with ENSPRYNG at a higher incidence than placebo. Monitor neutrophils during treatment.

What to do in case of emergency/overdose?

In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

Can this medicine be used in pregnancy?

  • There are no adequate data on the developmental risk associated with the use of ENSPRYNG in pregnant women.

Can this medicine be used in children?

  • Safety and effectiveness in pediatric patients have not been established.

What should I know about storage and disposal of this medication?

  • Refrigerate at 2°C to 8°C (36°F to 46°F) in original carton to protect from light. Do not freeze. Do not shake.
  • Prior to administration, ENSPRYNG, if unopened, can be removed from and returned to the refrigerator, if necessary. The total combined time out of refrigeration should not exceed 8 days at a temperature that does not exceed 30°C (86°F).


Satralizumab-mwge Resources
Doctor showing form.jpg

Resources

Frequently asked questions

Faq-icon.png



Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Dr.T